Effects of low-dose ketamine on neuropathic pain: An electroencephalogram-electrooculogram/behavioral study (Q39405249)

11 September 2017

title

Effects of low-dose ketamine on neuropathic pain: An electroencephalogram-electrooculogram/behavioral study (English)

1 reference

11 September 2017

0 references

Kentaro Oga

1

1 reference

11 September 2017

Takuya Kojima

2

1 reference

11 September 2017

Masato Matsuura

3

1 reference

11 September 2017

Masanori Nagashima

4

1 reference

11 September 2017

Jitsu Kato

5

1 reference

11 September 2017

Shigeru Saeki

6

1 reference

11 September 2017

Setsuro Ogawa

7

1 reference

11 September 2017

publication date

1 August 2002

1 reference

Psychiatry and Clinical Neurosciences

11 September 2017

published in

1 reference

11 September 2017

volume

56

1 reference

11 September 2017

issue

4

1 reference

11 September 2017

page(s)

355-363

1 reference

Ketamine: an update on the first twenty-five years of clinical experience

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01023.X

Ketamine hydrochloride in the treatment of phantom limb pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01023.X

Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01023.X

The analgesic effect of racemic ketamine in patients with chronic ischemic pain due to lower extremity arteriosclerosis obliterans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01023.X

The effect of ketamine on phantom pain: a central neuropathic disorder maintained by peripheral input

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01023.X

Four years' treatment with ketamine and a trial of dextromethorphan in a patient with severe post-herpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01023.X

Oral ketamine therapy in the treatment of postamputation stump pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01023.X

Analgesic effect of oral ketamine in chronic neuropathic pain of spinal origin: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01023.X

Clinical experience with oral ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01023.X

NMDA-receptor antagonist in pain therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01023.X

Response of chronic neuropathic pain syndromes to ketamine: a preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01023.X

Evidence of a role for NMDA receptors in pain perception

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01023.X

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01023.X

Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01023.X

Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01023.X

Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01023.X

Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01023.X

Analgesic efficacy of low-dose ketamine. Somatosensory-evoked responses in relation to subjective pain ratings

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01023.X

Eye movements of waking subjects with closed eyes. A comparison between normals and chronic schizophrenics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01023.X

A psychophysiological study of the development of delirium in coronary care units.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01023.X

Neuronal mechanisms of ketamine-induced anesthesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01023.X

Ketamine induces failure of the oculomotor neural integrator in the cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01023.X

Neural circuits underlying ketamine-induced oculomotor behavior in the rat: 2-deoxyglucose studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01023.X

Multiple representations of pain in human cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01023.X

The cortical representation of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01023.X

Neural correlates of levels of emotional awareness. Evidence of an interaction between emotion and attention in the anterior cingulate cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01023.X

Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01023.X

Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01023.X

Eeg alpha rhythm and glucose metabolic rate in the thalamus in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01023.X

10.1046/J.1440-1819.2002.01023.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference